Connection

William Creasman to Uterine Cervical Neoplasms

Back to Details
This is a "connection" page, showing publications William Creasman has written about Uterine Cervical Neoplasms.
William Creasman
Connection Strength
4.450
Uterine Cervical Neoplasms
  1. Why do we continue to overtreat stage Ia?carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417.
    View in: PubMed
    Score: 0.465
  2. Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries. Am J Clin Oncol. 2016 Feb; 39(1):92-7.
    View in: PubMed
    Score: 0.425
  3. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3.
    View in: PubMed
    Score: 0.269
  4. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.
    View in: PubMed
    Score: 0.207
  5. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 2004 Feb; 92(2):525-9.
    View in: PubMed
    Score: 0.185
  6. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
    View in: PubMed
    Score: 0.183
  7. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6.
    View in: PubMed
    Score: 0.176
  8. Stage IA cancer of the cervix: finally some resolution of definition and treatment? Gynecol Oncol. 1999 Aug; 74(2):163-4.
    View in: PubMed
    Score: 0.135
  9. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1998 Jan; 178(1 Pt 1):62-5.
    View in: PubMed
    Score: 0.121
  10. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07; 390(10103):1654-1663.
    View in: PubMed
    Score: 0.118
  11. New gynecologic cancer staging. Gynecol Oncol. 1995 Aug; 58(2):157-8.
    View in: PubMed
    Score: 0.103
  12. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 1995 Jun; 57(3):412-6.
    View in: PubMed
    Score: 0.102
  13. Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. Gynecol Oncol. 1994 Nov; 55(2):313-7.
    View in: PubMed
    Score: 0.098
  14. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8.
    View in: PubMed
    Score: 0.089
  15. A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8.
    View in: PubMed
    Score: 0.082
  16. Is laser surgery superior to cryosurgery for the treatment of high grade CIN? Con. J Gynecol Surg. 1991; 7(1):57-9.
    View in: PubMed
    Score: 0.075
  17. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990 Jun; 37(3):390-5.
    View in: PubMed
    Score: 0.072
  18. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989 Oct; 7(10):1462-8.
    View in: PubMed
    Score: 0.069
  19. How good (or bad) is the Pap smear? J S C Med Assoc. 1989 Oct; 85(10):459-62.
    View in: PubMed
    Score: 0.069
  20. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94.
    View in: PubMed
    Score: 0.063
  21. Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.
    View in: PubMed
    Score: 0.063
  22. Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies. Gynecol Oncol. 1988 Mar; 29(3):283-9.
    View in: PubMed
    Score: 0.061
  23. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007 Aug; 106(2):362-9.
    View in: PubMed
    Score: 0.058
  24. Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol. 1987 Feb; 26(2):160-8.
    View in: PubMed
    Score: 0.057
  25. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb; 69(2):151-5.
    View in: PubMed
    Score: 0.057
  26. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol. 1986 Nov; 155(5):964-9.
    View in: PubMed
    Score: 0.056
  27. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
    View in: PubMed
    Score: 0.056
  28. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol. 1985 Sep 15; 153(2):164-72.
    View in: PubMed
    Score: 0.052
  29. Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynecol. 1985 Jan; 65(1):73-6.
    View in: PubMed
    Score: 0.049
  30. The significance of peritoneal cytology in patients with carcinoma of the cervix. Gynecol Oncol. 1984 Feb; 17(2):139-48.
    View in: PubMed
    Score: 0.046
  31. Cryosurgery in the management of cervical intraepithelial neoplasia. Obstet Gynecol. 1984 Feb; 63(2):145-9.
    View in: PubMed
    Score: 0.046
  32. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:41-78.
    View in: PubMed
    Score: 0.045
  33. Cryotherapy in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 1983 Sep; 62(3):353-8.
    View in: PubMed
    Score: 0.045
  34. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol. 1983 Jan; 61(1):87-94.
    View in: PubMed
    Score: 0.043
  35. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol. 1981 Dec 15; 141(8):921-9.
    View in: PubMed
    Score: 0.040
  36. Results of outpatient therapy of cervical intraepithelial neoplasia. Gynecol Oncol. 1981 Oct; 12(2 Pt 2):S306-16.
    View in: PubMed
    Score: 0.039
  37. The abnormal Pap smear--what to do next? Cancer. 1981 Jul 15; 48(2 Suppl):515-22.
    View in: PubMed
    Score: 0.039
  38. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol. 2001 Jan; 184(2):64-9.
    View in: PubMed
    Score: 0.037
  39. Conservative management of cervical intraepithelial neoplasia. Clin Obstet Gynecol. 1980 Mar; 23(1):281-91.
    View in: PubMed
    Score: 0.035
  40. Unusual metastasis in carcinoma of the cervix uteri. Surg Gynecol Obstet. 1979 May; 148(5):728-30.
    View in: PubMed
    Score: 0.033
  41. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999 Jan; 64(1):5-10.
    View in: PubMed
    Score: 0.033
  42. Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma. Am J Obstet Gynecol. 1978 Nov 01; 132(5):555-60.
    View in: PubMed
    Score: 0.032
  43. Management of early cervical neoplasia. Clin Obstet Gynecol. 1975 Sep; 18(3):233-45.
    View in: PubMed
    Score: 0.026
  44. Meningeal carcinomatosis secondary to advanced squamous cell carcinoma of the cervix: a case report. Meningeal metastasis of advenced cervical cancer. Gynecol Oncol. 1975 Sep; 3(3):201-4.
    View in: PubMed
    Score: 0.026
  45. Is positive pelvic lymphadenopathy a contraindication to radical surgery in recurrent cervical carcinoma? Gynecol Oncol. 1974 Dec; 2(4):482-5.
    View in: PubMed
    Score: 0.025
  46. Microinvasive carcinoma of the cervix. Clin Obstet Gynecol. 1973 Jun; 16(2):261-75.
    View in: PubMed
    Score: 0.022
  47. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynecol. 1973 Apr; 41(4):501-6.
    View in: PubMed
    Score: 0.022
  48. Preoperative evaluation of patients with recurrent carcinoma of the cervix. Gynecol Oncol. 1972 Nov; 1(1):111-8.
    View in: PubMed
    Score: 0.021
  49. Carcinoma in situ of the cervix. An analysis of 861 patients. Obstet Gynecol. 1972 Mar; 39(3):373-80.
    View in: PubMed
    Score: 0.020
  50. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992 Jan; 166(1 Pt 1):50-3.
    View in: PubMed
    Score: 0.020
  51. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990 Sep; 38(3):352-7.
    View in: PubMed
    Score: 0.018
  52. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Dec; 35(3):314-20.
    View in: PubMed
    Score: 0.017
  53. Percutaneous nephrostomy in gynecologic oncology patients. Am J Obstet Gynecol. 1988 May; 158(5):1126-31.
    View in: PubMed
    Score: 0.016
  54. Evaluation of the atypical Pap smear. Am J Obstet Gynecol. 1987 Sep; 157(3):544-9.
    View in: PubMed
    Score: 0.015
  55. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984 Sep; 19(1):8-16.
    View in: PubMed
    Score: 0.012
  56. Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report. Am J Obstet Gynecol. 1984 Aug 01; 149(7):796-8.
    View in: PubMed
    Score: 0.012
  57. Cytopathology and the management of early invasive cancer of the uterine cervix. Obstet Gynecol. 1982 Sep; 60(3):350-3.
    View in: PubMed
    Score: 0.010
  58. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980 Feb; 9(1):90-8.
    View in: PubMed
    Score: 0.009
  59. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2089-92.
    View in: PubMed
    Score: 0.009
  60. Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1979 Mar; 5(3):323-6.
    View in: PubMed
    Score: 0.008
  61. Treatment of cervical dysplasia with electrocautery and tetracycline suppositories. Am J Obstet Gynecol. 1973 Oct 15; 117(4):460-3.
    View in: PubMed
    Score: 0.006
  62. Unreliability of urinary cytology in detecting gynecologic malignancy. Cancer. 1972 Jul; 30(1):148-9.
    View in: PubMed
    Score: 0.005
  63. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol. 1971 Jul 15; 110(6):773-81.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.